Skip to main content

Herpes Zoster with JAK Inhibitors A recent review a higher HZ risk with JAKi therapy shows the HZ-risk in RA and UC to

Feb 05, 2023 2:00 pm
Social Author Name
Dr. John Cush
Tweet Content
Herpes Zoster with JAK Inhibitors A recent review a higher HZ risk with JAKi therapy shows the HZ-risk in RA and UC to be higher than PsA when treated with usual doses of TOFA, especially those given higher TOFA doses or concomitant glucocorticoids. https://t.co/rlYXJWONyS https://t.co/nwqbbp6Ci3
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×